Malignant Liver Tumors in Children

• Von Schweinitz D : Management of liver tumors in childhood.Semin. Pediatr. Surg.15, 17–24(2006).
   PubMedGoogle Scholar
• Meyers RL , ScaifeER: Benign liver and biliary tract masses in infants and toddlers.Semin. Pediatr. Surg.9, 145–146(2000).
   Google Scholar
• Christison-Lagay ER , BurrowsPE, Alomari A et al.: Hepatic hemangiomas: subtype classification and development of a clinical practice algorithm and registry. J. Pediatr. Surg.42, 62–68(2007).
   PubMed Web of Science ®Google Scholar
• Stringer MD , AlizaiNK: Mesenchymal hamartoma of the liver: a systematic review.J. Pediatr. Surg.40, 1681–1690(2005).
   PubMed Web of Science ®Google Scholar
• Stringer MD : Liver tumors.Semin. Pediatr. Surg.9, 196–208(2000).
   PubMedGoogle Scholar
• Prokurat A , KlugeP, KoscieszaAet al.: Transitional liver cell tumors (TLCT) in older children and adolescents: a novel group of aggressive hepatic tumors expressing β-catenin. Med. Pediatr. Oncol.39, 510–518(2002).
   PubMedGoogle Scholar
• Oue T , KubotaA, OkuyamaHet al.: Hepatoblastoma in children of extremely low birth weight: a report from a single prenatal center. J. Pediatr. Surg.38, 134–137(2003).
   PubMed Web of Science ®Google Scholar
• Aretz S , KochA, UhlhaasSet al.: Should children at risk for familial adenomatous polyposis be screened for hepatoblastoma and children with apparently sporadic hepatoblastoma be screened for APC germline mutations. Pediatr. Blood Cancer47, 811–818(2006).
   PubMed Web of Science ®Google Scholar
• Hirschman BA , PollockBH, Tomlinson GE: The spectrum of APC mutations in children with hepatoblastoma from familial adenomatous polyposis kindreds. J. Pediatr.147, 263–266(2005).
   PubMed Web of Science ®Google Scholar
• Tomlinson GE , DouglassEC, PollockBHet al.: Cytogenetic analysis of a large series of hepatoblastoma: numerical aberrations with recurring translocations involving 1q12–21. Genes Chromosomes Cancer44, 177–184(2006).
   Web of Science ®Google Scholar
• Otte JB : Should the selection of children with hepatocellular carcinoma be based on Milan criteria?Pediatr. Transplant.12, 1–3(2008).
   PubMed Web of Science ®Google Scholar
• Kohno M , KitataniH, WadaHet al.: Hepatocellular carcinoma complicating biliary cirrhosis caused by biliary atresia. J. Pediatr. Surg.30, 1713–1716(1995).
   PubMed Web of Science ®Google Scholar
• Brunati A , FeruziZ, SokalEet al.: Early occurrence of hepatocellular carcinoma in biliary atresia treated by liver transplantation. Pediatr. Transplant.11, 117–119(2007).
   PubMed Web of Science ®Google Scholar
• Knisely AS , StrautnieksSS, MeierYet al.: Hepatocellular carcinoma in ten children under 5 years of age with bile salt export pumps deficiency. Hepatology44, 478–486(2006).
   PubMed Web of Science ®Google Scholar
• Castiloux J , LabergeAM, MartinSRet al.: ‘Silent’ tyrosinemia presenting as hepatocellular carcinoma in a 10-year-old girl. J. Pediatr. Gastroenterol. Nutr.44, 375–377(2007).
   PubMed Web of Science ®Google Scholar
• Imkie M , MyersSA, LiYet al.: Fibrolamellar hepatocellular carcinoma arising in a background of focal nodular hyperplasia. J. Reprod. Med.50, 633–637(2005).
   PubMed Web of Science ®Google Scholar
• Meyers RL , KatzensteinHM, KrailoMet al.: Surgical resection of pulmonary metastatic lesions in children with hepatoblastoma. J. Pediatr. Surg.42, 2050–2056(2007).
   PubMed Web of Science ®Google Scholar
• Perilongo G , ShaffordE, MaibachRet al.: Risk adapted treatment for childhood hepatoblastoma: final report of the second study of the Internatinal Society of Pediatric Oncology – SIOPEL 2. Eur. J. Cancer40, 411–421(2004).
   PubMed Web of Science ®Google Scholar
• Fuchs J , RydzynskiJ, von Schweinitz D et al.: Pretreatment prognostic factors and treatment results in children with hepatoblastoma: a report from the German Cooperative Pediatric Liver Tumor Study HB 94. Cancer95, 172–182(2002).
   PubMed Web of Science ®Google Scholar
• Tsuchida Y , IkedaH, SuzukiNet al.: A case of well-differentiated, fetal-type hepatoblastoma with very low serum α-fetoprotein. J. Pediatr. Surg.34, 1762–1764(1999).
   PubMed Web of Science ®Google Scholar
• Sari N , YalcinB, AkyuzCet al.: Infantile hepatic hemangioendothelioma with very elevated serum α-fetoprotein. Pediatr. Hematol. Oncol.23, 639–647(2006).
   PubMed Web of Science ®Google Scholar
• Cajalba MM , Sarita-ReyesC, Zambrano E et al.: Mesenchymal hamartoma of the liver associated with features of Beckwith–Weidemann syndrome and high serum α-fetoprotein levels. Pediatr. Dev. Pathol.10, 233–238(2007).
   PubMed Web of Science ®Google Scholar
• Boman F , BossardC, FabreMet al.: Mesenchymal hamartomas of the liver may be associated with increased serum α-fetoprotein concentrations and mimic hepatoblastoma. Eur. J. Pediatr. Surg.14, 63–66(2004).
   PubMedGoogle Scholar
• Wang JD , ChangTK, ChenHCet al.: Pediatric liver tumors: initial presentation, image finding and outcome. Pediatr. Int.49, 491–496(2007).
   PubMed Web of Science ®Google Scholar
• Aronson DC , SchnaterJM, StaalmanCRet al.: Predictive value of the pretreatment extent of disease system in hepatoblastoma: results from the International Society of Pediatric Oncology Liver Tumor Study Group SIOPEL-1 study. J. Clin. Oncol.23, 1245–1252(2005).
   PubMed Web of Science ®Google Scholar
• Roebuck DJ , AronsonD, ClaypuytPet al.: 2005 PRETEXT: a revised staging system for primary malignant tumors of childhood developed by the SIOPEL group. Pediatr. Radiol.37, 1096–1100(2007).
   PubMed Web of Science ®Google Scholar
• Saar B , KellnerF: Radiological diagnosis of hepatocelluar carcinoma.Liver Int.28, 188–199(2008).
   Web of Science ®Google Scholar
• Malogolowkin MH , KatzensteinHM, KrailoMet al.: Intensified platinum therapy is an ineffective strategy for improving outcome in pediatric patients with advanced hepatoblastoma. J. Clin. Oncol.24, 2879–2884(2006).
   PubMed Web of Science ®Google Scholar
• Haas JE , FeusnerJH, FinegoldMJ: Small cell undifferentiated histology in hepatoblastoma may be unfavorable.Cancer92, 3130–3134(2001).
   PubMed Web of Science ®Google Scholar
• Meyers RL , RowlandJH, KrailoMet al.: PRETEXT and other prognostic factors in hepatoblastoma: a Report of the Children’s Oncology Group. Pediatr. Blood Cancer (2008) (In Press).
   Google Scholar
• Katzenstein HM : The current COG approach to the treatment of childhood hepatoblastoma. Presented at: The First International Symposium Childhood Hepatoblastoma. Gdansk, Poland, 22–23 March (2007).
   Google Scholar
• Ortega JA , Douglass,EC, FeusnerJHet al.: Randomized comparison of cisplatin/vincristin/5-fluorouracil and cisplatin/doxorubicin for the treatment of pediatric hepatoblastoma (HB): a report from the Children’s Cancer Group and the Pediatric Oncology Group. J. Clin. Oncol.18, 2665–2675(2000).
   PubMed Web of Science ®Google Scholar
• Schnater JM , AronsonDC, PlaschkesJet al.: Surgical view of the treatment of patients with hepatoblastoma: results from the first prospective trial of SIOPEL. Cancer94, 1111–1120(2002).
   PubMed Web of Science ®Google Scholar
• Perilongo G : The current SIOPEL approach to the treatment of childhood hepatoblastoma. Presented at: The First International Symposium Childhood Hepatoblastoma. Gdansk, Poland, 22–23 March (2007).
   Google Scholar
• von Schweinitz D : The current German approach to the treatment of childhood hepatoblastoma. Presented at: The First International Symposium Childhood Hepatoblastoma. Gdansk, Poland, 22–23 March (2007).
   Google Scholar
• Hishiki T : The current Japanese approach to the treatment of childhood hepatoblastoma. Presented at: First International Symposium Childhood Hepatoblastoma. Gdansk, Poland, 22–23 March (2007).
   Google Scholar
• Malogolowkin MH , KatzensteinHM, KrailoMet al.: Redefining the role of doxorubicin for the treatment of children with hepatoblastoma. J. Clin. Oncol.10, 2379–2383(2008).
   Google Scholar
• Von Schweinitz D , HeckerH, HarmsDet al.: Complete resection before development of drug resistance is essential for survival from advanced hepatoblastoma – a report from the German Cooperative Pediatric Liver tumor Study HB-89. J. Pediatr. Surg.30, 845–852(1995).
   PubMed Web of Science ®Google Scholar
• Warmann SW , FuchsJ: Drug resistance in hepatoblastoma.Curr. Pharm. Biotechnol.8, 93–97(2007).
   PubMed Web of Science ®Google Scholar
• Muldoon LL , PagelMA, KrollRAet al.: Delayed administration of sodium thiosulfate in animal models reduces platinum ototoxicity without reduction of antitumor activity. Clin. Cancer Res.6, 309–315(2000).
   PubMed Web of Science ®Google Scholar
• Otte JB , deVille de Goyet J, Reding R: Liver transplantation for hepatoblastoma: indications and contraindications in the modern era. Pediatr. Transplant.9, 557–656(2005).
   PubMed Web of Science ®Google Scholar
• Chardot C , Sant Martin C, Gilles A et al.: Living related liver transplantation and vena cava reconstruction after total hepatectomy including the vena cava for hepatoblastoma. Transplantation73, 90–92(2002).
   PubMed Web of Science ®Google Scholar
• Czauderna P , OtteJB, AronsonDCet al.: Guidelines for surgical treatment of hepatoblastoma in the modern era: Recommendations from the childhood Liver Tumour Strategy Group of the International Society of Paediatric Oncology (SIOPEL). Eur. J. Cancer41, 1031–1036(2005).
   PubMed Web of Science ®Google Scholar
• Dall‘Igna P , CecchettoG, ToffoluttiTet al.: Multifocal hepatoblastoma: is there a place for partial hepatectomy? Med. Pediatr. Oncol.40, 113–117(2003).
   PubMedGoogle Scholar
• Millar AJW , HartleyP, KhanDet al.: Extended hepatic resection with transplantation back-up for an unresectable tumor. Pediatr. Surg. Int.17, 378–381(2001).
   PubMed Web of Science ®Google Scholar
• Czauderna P , MacKinleyG, PerilongoGet al.: Hepatocellular carcinoma in children: results of the first prospective study of the International Society of Pediatric Oncology Group. J. Clin. Oncol.20, 2798–2804(2002).
   PubMed Web of Science ®Google Scholar
• Katzenstein HM , KrailoMD, MalogolowkinMHet al.: Hepatocellular carcinoma in children and adolescents: results from the Pediatric Oncology Group and the Children’s Cancer Group Study. J. Clin. Oncol.29, 2980–2897(2002).
   Google Scholar
• Katzenstein HM , KrailoMD, MalogolowkinMHet al.: Fibrolamellar hapatocellular carcinoma in children and adolescents. Cancer97, 2006–2012(2003).
   PubMed Web of Science ®Google Scholar
• Beaunoyer M , VanattaJM, OgiharaMet al.: Outcomes of transplantation in children with primary hepatic malignancy. Pediatr. Transplant12, 1–3(2007).
   PubMedGoogle Scholar
• Gille J , SpiethK, KaufmannR: Metronomic low-dose chemotherapy as antiangiogenic therapeutic strategy for cancer.J. Dtsch Dermatol. Ges.3, 26–32(2005).
   PubMedGoogle Scholar
• Meng F , HensonR, PatelT: Chemotherapeutic stress selectively activates NF-κB dependent Akt and VEGF expression in liver cancer derived endothelial cells.Am. J. Physiol. Cell Physiol.293, C749–C760 (2007).
   PubMed Web of Science ®Google Scholar
• Pang R , PoonRT: Angiogenesis and antiangiogenic therapy in hepatocellular carcinoma.Cancer Lett.242, 151–167(2006).
   PubMed Web of Science ®Google Scholar
• Skelton MR , O‘NeilB: Targeted therapies for hepatocellular carcinoma.Clin. Adv. Hematol. Oncol.6, 209–218(2008).
   PubMedGoogle Scholar
• Weitz J , KlimstraDS, CymesKet al.: Management of primary liver sarcomas. Cancer109, 1391–1396(2007).
   PubMed Web of Science ®Google Scholar
• Spunt SL , LobeTE, PappoAet al.: Aggressive surgery is unwarranted for biliary tract rhabdomyosarcoma. J. Pediatr. Surg.35, 309–316(2000).
   PubMed Web of Science ®Google Scholar
• Nazir Z , PervezS: Malignant vascular tumors of liver in neonates.J. Pediatr. Surg.41, e49–e51 (2006).
   PubMed Web of Science ®Google Scholar
• Awan S , DavenportM, PortmannBet al.: Angiosarcoma of the liver in children. J. Pediatr. Surg.31, 1729–1732(1996).
   PubMed Web of Science ®Google Scholar
• Ravindra KV , CullinaneC, LewisIJet al.: Long-term survival after spontaneous rupture of a malignant rhabdoid tumor of the liver. J. Pediatr. Surg.37, 1488–1490(2002).
   PubMed Web of Science ®Google Scholar
• Clairotte A , RingenbachR, LaithierVet al.: Malignant rhabdoid tumor of the liver with spontaneous rupture: a case report. Ann. Pathol.26, 122–125(2006).
   PubMed Web of Science ®Google Scholar
• Bisogno G , PilzT, PerilongoGet al.: Undifferentiated sarcoma of the liver in childhood: a curable disease. Cancer94, 252–257(2002).
   PubMed Web of Science ®Google Scholar
• Kim DY , KimKH, JungSEet al.: Undifferentiated (embryonal) sarcoma of the liver: combination treatment by surgery and chemotherapy. J. Pediatr. Surg.37, 1419–1423(2002).
   PubMed Web of Science ®Google Scholar
• Baron PW , MajiessipourF, BedrosAAet al.: Undifferentiated embryonal sarcoma of the liver successfully treated with chemotherapy and liver resection. J. Gastrointest. Surg.11, 73–75(2007).
   PubMed Web of Science ®Google Scholar
• Su WT , RutigilanoDN, GhollizadehMet al.: Hepatic metastasectomy in children. Cancer109, 2089–2092(2007).
   PubMed Web of Science ®Google Scholar
• Citak EC , KaradeniaC, OquzAet al.: Nodular regenerative hyperplasia and focal nodular hyperplasia of the liver mimicking hepatic metastasis in children with solid tumors and a review of the literature. Pediatr. Hematol. Oncol.24, 281–289(2007).
   PubMed Web of Science ®Google Scholar

Websites

• Hepatoblastoma Origins and Pediatric Epidemiology: The HOPE study. www.cancer.umn.edu/hopestudy
   Google Scholar
• The Pediatric Liver Unresectable Tumor Observatory (PLUTO) registry. http://pluto.cineca.org
   Google Scholar